Page last updated: 2024-08-25

g 25671 and uric acid

g 25671 has been researched along with uric acid in 1 studies

*Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN. [MeSH]

*Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BRODIE, BB; BURNS, JJ; GUTMAN, AB; PEREL, JM; RITTERBAND, A; YU, TF1

Other Studies

1 other study(ies) available for g 25671 and uric acid

ArticleYear
A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671.
    The Journal of pharmacology and experimental therapeutics, 1957, Volume: 119, Issue:3

    Topics: Analgesics; Phenylbutazone; Safrole; Sulfinpyrazone; Sulfoxides; Uric Acid; Uricosuric Agents

1957